Royalties Payments. 3.1 LICENSEE shall make:
Royalties Payments. Lessee shall pay to Lessor, a four percent (4%) gross production royalty from the sale or disposition of minerals, metal and materials taken from "The Property" leased to Lessee and covered by this Lease. All payments made under this agreement shall be made to Lessor by Lessee within fifteen (15) days from that date that the buyer makes final settlement with Lessee. Payments shall be made either in person or to the address under which Lessor enters this agreement. Payment made to the Lessor shall be accompanied by the sales slip showing the basis upon which the sale has been made. All settlement sheets or sales slips shall be marked as sold from "The Property". In consideration for this Lease, Lessee will pay Lessor $1000 upon signing, $5,000 March 15th 2004 and a minimum annual royalty of $6,000 Jan 1st 2005, $8,000 Jan 1st 2006, $10,000 Jan 1st 2007, $12,000 Jan 1st 2008 and $12,000 Jan 1st every year there after as long as this Lease is in effect. All minimum annual royalties shall be applied to actual royalties.
Royalties Payments. 3.1. Royalties In consideration for the rights granted under Article II, except as provided in Article VI hereof, LICENSEE shall make royalty payments to LICENSOR for the Run-Time Software, pursuant to Addendum C.
Royalties Payments. 6.1 Licensee will pay to Monash earned royalties based on aggregate Net Sales of Licensed Products in the Licensed Territory by or on behalf of Licensee, its Affiliates, and its Sublicensees (as applicable) in a given Calendar Year during the Royalty Term, on an incremental percentage basis as set forth below: Royalty rate Portion of Net Sales in the Licensed Territory in a Calendar Year (U.S. dollars) [***] [***] [***] [***] For clarity, the royalty rates set forth in the table in this Section 6.1 are intended to be applied incrementally, with the specified royalty rate applying to the portion of Net Sales in the Licensed Territory in a given Calendar Year that fall within the range to which such royalty rate applies. Royalties will be payable on a Licensed Product-by-Licensed Product and country-by-country basis until the expiry of the Royalty Term for such Licensed Product in such country. Any royalties paid by Licensee to Monash under this Section 6.1 during a Calendar Year shall be creditable against any Annual License Maintenance Fee described in Section 5.2 for such Calendar Year.
Royalties Payments. After receiving the Statement, ChromaDex shall submit an invoice to NHSc in the amount indicated on the Statement and NHSc shall pay such invoice within [***] of the invoice date. 4.8
Royalties Payments. 4.1. LICENSEE shall make royalty payments to LICENSOR on Net Hardware Unit Sales by LICENSEE or any Third Party. No Hardware Unit however is to be counted more than one time for royalty computation purposes hereunder.
Royalties Payments. No specific royalties shall be due under this Agreement for the grant of the License; however, the Parties hereby agree to supply the other Party’s reasonable requirements of Products for the pre-determined price. The Parties hereby agree that each Party shall maintain the exclusive right to manufacture its Product, and the Licensee shall purchase all EDCI Products exclusively from Licensor. Licensor shall purchase all BGF Products exclusively from Licensee. All other equipment required for construction and operation of a Project utilizing the Technology may be purchased from other vendors.
Royalties Payments. STOCK AND REIMBURSEMENT --------------------------------------------
Royalties Payments. 2.1 Bioenvision shall pay to WinWin a royalty of 10% of net sale price for Products sold directly by Bioenvision or any of its subsidiaries. Net sale price is defined as the total sale price charge by Bioenvision or its subsidiaries minus discounts and tax.
Royalties Payments. 2.1 Bioenvision shall pay to Stegram a royalty of 10% of net sale price for product sold directly by Bioenvision or any of its subsidiaries. Net sale price is defined as the total sale price charged by Bioenvision or its subsidiaries minus discounts and tax. After expiry of the last patent a royalty of 5% of net sales shall be payable so long as Bioenvision uses any Trademarks owned by Stegram.
